nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Tamoxifen—pancreatic cancer	0.0601	0.0818	CbGbCtD
Zafirlukast—CYP2E1—Dacarbazine—pancreatic cancer	0.0539	0.0733	CbGbCtD
Zafirlukast—ABCG2—Erlotinib—pancreatic cancer	0.0511	0.0695	CbGbCtD
Zafirlukast—ABCG2—Irinotecan—pancreatic cancer	0.0462	0.0628	CbGbCtD
Zafirlukast—ABCG2—Fluorouracil—pancreatic cancer	0.0443	0.0603	CbGbCtD
Zafirlukast—CYP2E1—Tamoxifen—pancreatic cancer	0.0429	0.0583	CbGbCtD
Zafirlukast—ABCG2—Docetaxel—pancreatic cancer	0.0338	0.046	CbGbCtD
Zafirlukast—ABCG2—Sunitinib—pancreatic cancer	0.0337	0.0458	CbGbCtD
Zafirlukast—CYP2C8—Tamoxifen—pancreatic cancer	0.032	0.0436	CbGbCtD
Zafirlukast—CYP1A2—Dacarbazine—pancreatic cancer	0.0312	0.0424	CbGbCtD
Zafirlukast—CYP2C8—Erlotinib—pancreatic cancer	0.0272	0.037	CbGbCtD
Zafirlukast—CYP2C19—Tamoxifen—pancreatic cancer	0.0269	0.0365	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—pancreatic cancer	0.0252	0.0343	CbGbCtD
Zafirlukast—CYP1A2—Tamoxifen—pancreatic cancer	0.0248	0.0337	CbGbCtD
Zafirlukast—CYP2C8—Fluorouracil—pancreatic cancer	0.0236	0.0321	CbGbCtD
Zafirlukast—CYP2C9—Tamoxifen—pancreatic cancer	0.0223	0.0304	CbGbCtD
Zafirlukast—CYP1A2—Erlotinib—pancreatic cancer	0.0211	0.0287	CbGbCtD
Zafirlukast—CYP2D6—Tamoxifen—pancreatic cancer	0.0204	0.0278	CbGbCtD
Zafirlukast—CYP1A2—Fluorouracil—pancreatic cancer	0.0183	0.0248	CbGbCtD
Zafirlukast—CYP2D6—Erlotinib—pancreatic cancer	0.0174	0.0236	CbGbCtD
Zafirlukast—CYP2C9—Fluorouracil—pancreatic cancer	0.0165	0.0224	CbGbCtD
Zafirlukast—CYP3A4—Tamoxifen—pancreatic cancer	0.013	0.0177	CbGbCtD
Zafirlukast—CYP3A4—Erlotinib—pancreatic cancer	0.011	0.015	CbGbCtD
Zafirlukast—CYP3A4—Irinotecan—pancreatic cancer	0.00998	0.0136	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—pancreatic cancer	0.00857	0.0117	CbGbCtD
Zafirlukast—CYP3A4—Docetaxel—pancreatic cancer	0.00731	0.00994	CbGbCtD
Zafirlukast—CYP3A4—Sunitinib—pancreatic cancer	0.00728	0.0099	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—pancreatic cancer	0.00545	0.00741	CbGbCtD
Zafirlukast—Dyspepsia—Erlotinib—pancreatic cancer	0.000419	0.00235	CcSEcCtD
Zafirlukast—Neuropathy—Epirubicin—pancreatic cancer	0.000416	0.00234	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000415	0.00233	CcSEcCtD
Zafirlukast—Fatigue—Tamoxifen—pancreatic cancer	0.000415	0.00233	CcSEcCtD
Zafirlukast—Oedema—Sunitinib—pancreatic cancer	0.000412	0.00231	CcSEcCtD
Zafirlukast—Pain—Tamoxifen—pancreatic cancer	0.000411	0.00231	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000411	0.0023	CcSEcCtD
Zafirlukast—Fatigue—Erlotinib—pancreatic cancer	0.00041	0.0023	CcSEcCtD
Zafirlukast—Infection—Sunitinib—pancreatic cancer	0.000409	0.0023	CcSEcCtD
Zafirlukast—Pain—Erlotinib—pancreatic cancer	0.000407	0.00228	CcSEcCtD
Zafirlukast—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000403	0.00226	CcSEcCtD
Zafirlukast—Back pain—Irinotecan—pancreatic cancer	0.000402	0.00226	CcSEcCtD
Zafirlukast—Influenza like illness—Doxorubicin—pancreatic cancer	0.000399	0.00223	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000393	0.00221	CcSEcCtD
Zafirlukast—Back pain—Gemcitabine—pancreatic cancer	0.000392	0.0022	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000389	0.00218	CcSEcCtD
Zafirlukast—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000386	0.00216	CcSEcCtD
Zafirlukast—Neutropenia—Docetaxel—pancreatic cancer	0.000386	0.00216	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—pancreatic cancer	0.000385	0.00216	CcSEcCtD
Zafirlukast—Urticaria—Tamoxifen—pancreatic cancer	0.000382	0.00214	CcSEcCtD
Zafirlukast—Abdominal pain—Tamoxifen—pancreatic cancer	0.00038	0.00213	CcSEcCtD
Zafirlukast—Abdominal pain—Erlotinib—pancreatic cancer	0.000376	0.00211	CcSEcCtD
Zafirlukast—Body temperature increased—Erlotinib—pancreatic cancer	0.000376	0.00211	CcSEcCtD
Zafirlukast—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000376	0.00211	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000375	0.0021	CcSEcCtD
Zafirlukast—Malaise—Irinotecan—pancreatic cancer	0.000375	0.0021	CcSEcCtD
Zafirlukast—Insomnia—Sunitinib—pancreatic cancer	0.000373	0.00209	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000368	0.00207	CcSEcCtD
Zafirlukast—Malaise—Gemcitabine—pancreatic cancer	0.000365	0.00205	CcSEcCtD
Zafirlukast—Dyspepsia—Sunitinib—pancreatic cancer	0.000363	0.00203	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000361	0.00202	CcSEcCtD
Zafirlukast—Jaundice—Docetaxel—pancreatic cancer	0.000359	0.00201	CcSEcCtD
Zafirlukast—Hepatic failure—Epirubicin—pancreatic cancer	0.000358	0.00201	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000356	0.00199	CcSEcCtD
Zafirlukast—Fatigue—Sunitinib—pancreatic cancer	0.000355	0.00199	CcSEcCtD
Zafirlukast—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000354	0.00199	CcSEcCtD
Zafirlukast—Pain—Sunitinib—pancreatic cancer	0.000352	0.00198	CcSEcCtD
Zafirlukast—Discomfort—Irinotecan—pancreatic cancer	0.00035	0.00196	CcSEcCtD
Zafirlukast—Asthenia—Tamoxifen—pancreatic cancer	0.000345	0.00194	CcSEcCtD
Zafirlukast—Arthralgia—Gemcitabine—pancreatic cancer	0.000345	0.00193	CcSEcCtD
Zafirlukast—Myalgia—Gemcitabine—pancreatic cancer	0.000345	0.00193	CcSEcCtD
Zafirlukast—Agranulocytosis—Docetaxel—pancreatic cancer	0.000343	0.00192	CcSEcCtD
Zafirlukast—Asthenia—Erlotinib—pancreatic cancer	0.000341	0.00191	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000341	0.00191	CcSEcCtD
Zafirlukast—Discomfort—Gemcitabine—pancreatic cancer	0.000341	0.00191	CcSEcCtD
Zafirlukast—Pruritus—Tamoxifen—pancreatic cancer	0.00034	0.00191	CcSEcCtD
Zafirlukast—Oedema—Irinotecan—pancreatic cancer	0.000339	0.0019	CcSEcCtD
Zafirlukast—Myalgia—Fluorouracil—pancreatic cancer	0.000339	0.0019	CcSEcCtD
Zafirlukast—Infection—Irinotecan—pancreatic cancer	0.000337	0.00189	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000337	0.00189	CcSEcCtD
Zafirlukast—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000337	0.00189	CcSEcCtD
Zafirlukast—Pruritus—Erlotinib—pancreatic cancer	0.000337	0.00189	CcSEcCtD
Zafirlukast—Discomfort—Fluorouracil—pancreatic cancer	0.000335	0.00188	CcSEcCtD
Zafirlukast—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000332	0.00186	CcSEcCtD
Zafirlukast—Haemoglobin—Docetaxel—pancreatic cancer	0.000332	0.00186	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—pancreatic cancer	0.000331	0.00186	CcSEcCtD
Zafirlukast—Oedema—Gemcitabine—pancreatic cancer	0.000331	0.00185	CcSEcCtD
Zafirlukast—Haemorrhage—Docetaxel—pancreatic cancer	0.00033	0.00185	CcSEcCtD
Zafirlukast—Hepatitis—Docetaxel—pancreatic cancer	0.00033	0.00185	CcSEcCtD
Zafirlukast—Diarrhoea—Tamoxifen—pancreatic cancer	0.000329	0.00185	CcSEcCtD
Zafirlukast—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000329	0.00184	CcSEcCtD
Zafirlukast—Infection—Gemcitabine—pancreatic cancer	0.000328	0.00184	CcSEcCtD
Zafirlukast—Body temperature increased—Sunitinib—pancreatic cancer	0.000326	0.00183	CcSEcCtD
Zafirlukast—Abdominal pain—Sunitinib—pancreatic cancer	0.000326	0.00183	CcSEcCtD
Zafirlukast—Diarrhoea—Erlotinib—pancreatic cancer	0.000326	0.00183	CcSEcCtD
Zafirlukast—Oedema—Fluorouracil—pancreatic cancer	0.000325	0.00182	CcSEcCtD
Zafirlukast—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000324	0.00182	CcSEcCtD
Zafirlukast—Infection—Fluorouracil—pancreatic cancer	0.000323	0.00181	CcSEcCtD
Zafirlukast—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000318	0.00178	CcSEcCtD
Zafirlukast—Dizziness—Tamoxifen—pancreatic cancer	0.000318	0.00178	CcSEcCtD
Zafirlukast—Dizziness—Erlotinib—pancreatic cancer	0.000315	0.00176	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000312	0.00175	CcSEcCtD
Zafirlukast—Insomnia—Irinotecan—pancreatic cancer	0.000307	0.00172	CcSEcCtD
Zafirlukast—Vomiting—Tamoxifen—pancreatic cancer	0.000306	0.00172	CcSEcCtD
Zafirlukast—Hypersensitivity—Sunitinib—pancreatic cancer	0.000304	0.0017	CcSEcCtD
Zafirlukast—Rash—Tamoxifen—pancreatic cancer	0.000303	0.0017	CcSEcCtD
Zafirlukast—Dermatitis—Tamoxifen—pancreatic cancer	0.000303	0.0017	CcSEcCtD
Zafirlukast—Vomiting—Erlotinib—pancreatic cancer	0.000303	0.0017	CcSEcCtD
Zafirlukast—Headache—Tamoxifen—pancreatic cancer	0.000301	0.00169	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000301	0.00169	CcSEcCtD
Zafirlukast—Rash—Erlotinib—pancreatic cancer	0.0003	0.00168	CcSEcCtD
Zafirlukast—Dermatitis—Erlotinib—pancreatic cancer	0.0003	0.00168	CcSEcCtD
Zafirlukast—Insomnia—Gemcitabine—pancreatic cancer	0.000299	0.00168	CcSEcCtD
Zafirlukast—Dyspepsia—Irinotecan—pancreatic cancer	0.000299	0.00168	CcSEcCtD
Zafirlukast—Headache—Erlotinib—pancreatic cancer	0.000298	0.00167	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000297	0.00167	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000296	0.00166	CcSEcCtD
Zafirlukast—Asthenia—Sunitinib—pancreatic cancer	0.000296	0.00166	CcSEcCtD
Zafirlukast—Insomnia—Fluorouracil—pancreatic cancer	0.000294	0.00165	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000293	0.00164	CcSEcCtD
Zafirlukast—Fatigue—Irinotecan—pancreatic cancer	0.000293	0.00164	CcSEcCtD
Zafirlukast—Pruritus—Sunitinib—pancreatic cancer	0.000291	0.00163	CcSEcCtD
Zafirlukast—Pain—Irinotecan—pancreatic cancer	0.00029	0.00163	CcSEcCtD
Zafirlukast—Dyspepsia—Fluorouracil—pancreatic cancer	0.000286	0.0016	CcSEcCtD
Zafirlukast—Nausea—Tamoxifen—pancreatic cancer	0.000286	0.0016	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000285	0.0016	CcSEcCtD
Zafirlukast—Fatigue—Gemcitabine—pancreatic cancer	0.000285	0.0016	CcSEcCtD
Zafirlukast—Pain—Gemcitabine—pancreatic cancer	0.000283	0.00159	CcSEcCtD
Zafirlukast—Nausea—Erlotinib—pancreatic cancer	0.000283	0.00159	CcSEcCtD
Zafirlukast—Diarrhoea—Sunitinib—pancreatic cancer	0.000282	0.00158	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000281	0.00157	CcSEcCtD
Zafirlukast—Feeling abnormal—Irinotecan—pancreatic cancer	0.00028	0.00157	CcSEcCtD
Zafirlukast—Back pain—Docetaxel—pancreatic cancer	0.000278	0.00156	CcSEcCtD
Zafirlukast—Pain—Fluorouracil—pancreatic cancer	0.000278	0.00156	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000278	0.00156	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—pancreatic cancer	0.000276	0.00155	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000275	0.00154	CcSEcCtD
Zafirlukast—Dizziness—Sunitinib—pancreatic cancer	0.000272	0.00153	CcSEcCtD
Zafirlukast—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000272	0.00153	CcSEcCtD
Zafirlukast—Abdominal pain—Irinotecan—pancreatic cancer	0.000268	0.0015	CcSEcCtD
Zafirlukast—Body temperature increased—Irinotecan—pancreatic cancer	0.000268	0.0015	CcSEcCtD
Zafirlukast—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000268	0.0015	CcSEcCtD
Zafirlukast—Vomiting—Sunitinib—pancreatic cancer	0.000262	0.00147	CcSEcCtD
Zafirlukast—Body temperature increased—Gemcitabine—pancreatic cancer	0.000261	0.00147	CcSEcCtD
Zafirlukast—Neutropenia—Epirubicin—pancreatic cancer	0.00026	0.00146	CcSEcCtD
Zafirlukast—Rash—Sunitinib—pancreatic cancer	0.00026	0.00146	CcSEcCtD
Zafirlukast—Dermatitis—Sunitinib—pancreatic cancer	0.00026	0.00146	CcSEcCtD
Zafirlukast—Urticaria—Fluorouracil—pancreatic cancer	0.000258	0.00145	CcSEcCtD
Zafirlukast—Headache—Sunitinib—pancreatic cancer	0.000258	0.00145	CcSEcCtD
Zafirlukast—Body temperature increased—Fluorouracil—pancreatic cancer	0.000257	0.00144	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—pancreatic cancer	0.000255	0.00143	CcSEcCtD
Zafirlukast—Hypersensitivity—Irinotecan—pancreatic cancer	0.00025	0.0014	CcSEcCtD
Zafirlukast—Myalgia—Docetaxel—pancreatic cancer	0.000245	0.00137	CcSEcCtD
Zafirlukast—Arthralgia—Docetaxel—pancreatic cancer	0.000245	0.00137	CcSEcCtD
Zafirlukast—Nausea—Sunitinib—pancreatic cancer	0.000245	0.00137	CcSEcCtD
Zafirlukast—Asthenia—Irinotecan—pancreatic cancer	0.000243	0.00137	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000243	0.00136	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—pancreatic cancer	0.000242	0.00136	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—pancreatic cancer	0.000241	0.00135	CcSEcCtD
Zafirlukast—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000239	0.00134	CcSEcCtD
Zafirlukast—Asthenia—Gemcitabine—pancreatic cancer	0.000237	0.00133	CcSEcCtD
Zafirlukast—Oedema—Docetaxel—pancreatic cancer	0.000235	0.00132	CcSEcCtD
Zafirlukast—Pruritus—Gemcitabine—pancreatic cancer	0.000234	0.00131	CcSEcCtD
Zafirlukast—Infection—Docetaxel—pancreatic cancer	0.000233	0.00131	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—pancreatic cancer	0.000233	0.00131	CcSEcCtD
Zafirlukast—Diarrhoea—Irinotecan—pancreatic cancer	0.000232	0.0013	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—pancreatic cancer	0.000232	0.0013	CcSEcCtD
Zafirlukast—Pruritus—Fluorouracil—pancreatic cancer	0.00023	0.00129	CcSEcCtD
Zafirlukast—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00023	0.00129	CcSEcCtD
Zafirlukast—Diarrhoea—Gemcitabine—pancreatic cancer	0.000226	0.00127	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000225	0.00126	CcSEcCtD
Zafirlukast—Dizziness—Irinotecan—pancreatic cancer	0.000224	0.00126	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—pancreatic cancer	0.000224	0.00126	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—pancreatic cancer	0.000224	0.00125	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—pancreatic cancer	0.000223	0.00125	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—pancreatic cancer	0.000223	0.00125	CcSEcCtD
Zafirlukast—Diarrhoea—Fluorouracil—pancreatic cancer	0.000222	0.00125	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000222	0.00124	CcSEcCtD
Zafirlukast—Vomiting—Irinotecan—pancreatic cancer	0.000216	0.00121	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—pancreatic cancer	0.000215	0.00121	CcSEcCtD
Zafirlukast—Dizziness—Fluorouracil—pancreatic cancer	0.000215	0.00121	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000214	0.0012	CcSEcCtD
Zafirlukast—Rash—Irinotecan—pancreatic cancer	0.000214	0.0012	CcSEcCtD
Zafirlukast—Dermatitis—Irinotecan—pancreatic cancer	0.000214	0.0012	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000214	0.0012	CcSEcCtD
Zafirlukast—Headache—Irinotecan—pancreatic cancer	0.000213	0.00119	CcSEcCtD
Zafirlukast—Insomnia—Docetaxel—pancreatic cancer	0.000212	0.00119	CcSEcCtD
Zafirlukast—Vomiting—Gemcitabine—pancreatic cancer	0.00021	0.00118	CcSEcCtD
Zafirlukast—Rash—Gemcitabine—pancreatic cancer	0.000208	0.00117	CcSEcCtD
Zafirlukast—Dermatitis—Gemcitabine—pancreatic cancer	0.000208	0.00117	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—pancreatic cancer	0.000207	0.00116	CcSEcCtD
Zafirlukast—Headache—Gemcitabine—pancreatic cancer	0.000207	0.00116	CcSEcCtD
Zafirlukast—Vomiting—Fluorouracil—pancreatic cancer	0.000207	0.00116	CcSEcCtD
Zafirlukast—Dyspepsia—Docetaxel—pancreatic cancer	0.000207	0.00116	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—pancreatic cancer	0.000206	0.00116	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—pancreatic cancer	0.000206	0.00116	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000205	0.00115	CcSEcCtD
Zafirlukast—Rash—Fluorouracil—pancreatic cancer	0.000205	0.00115	CcSEcCtD
Zafirlukast—Dermatitis—Fluorouracil—pancreatic cancer	0.000205	0.00115	CcSEcCtD
Zafirlukast—Headache—Fluorouracil—pancreatic cancer	0.000204	0.00114	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000203	0.00114	CcSEcCtD
Zafirlukast—Fatigue—Docetaxel—pancreatic cancer	0.000202	0.00113	CcSEcCtD
Zafirlukast—Nausea—Irinotecan—pancreatic cancer	0.000202	0.00113	CcSEcCtD
Zafirlukast—Pain—Docetaxel—pancreatic cancer	0.000201	0.00113	CcSEcCtD
Zafirlukast—Nausea—Gemcitabine—pancreatic cancer	0.000196	0.0011	CcSEcCtD
Zafirlukast—Feeling abnormal—Docetaxel—pancreatic cancer	0.000193	0.00108	CcSEcCtD
Zafirlukast—Nausea—Fluorouracil—pancreatic cancer	0.000193	0.00108	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000192	0.00108	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—pancreatic cancer	0.000188	0.00105	CcSEcCtD
Zafirlukast—Abdominal pain—Docetaxel—pancreatic cancer	0.000185	0.00104	CcSEcCtD
Zafirlukast—Body temperature increased—Docetaxel—pancreatic cancer	0.000185	0.00104	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00018	0.00101	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—pancreatic cancer	0.000175	0.000981	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—pancreatic cancer	0.000174	0.000973	CcSEcCtD
Zafirlukast—Hypersensitivity—Docetaxel—pancreatic cancer	0.000173	0.000969	CcSEcCtD
Zafirlukast—Asthenia—Docetaxel—pancreatic cancer	0.000168	0.000944	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000166	0.000933	CcSEcCtD
Zafirlukast—Pruritus—Docetaxel—pancreatic cancer	0.000166	0.000931	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—pancreatic cancer	0.000165	0.000926	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—pancreatic cancer	0.000165	0.000926	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—pancreatic cancer	0.000163	0.000915	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—pancreatic cancer	0.000162	0.000907	CcSEcCtD
Zafirlukast—Diarrhoea—Docetaxel—pancreatic cancer	0.000161	0.0009	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—pancreatic cancer	0.000158	0.000887	CcSEcCtD
Zafirlukast—Infection—Epirubicin—pancreatic cancer	0.000157	0.000882	CcSEcCtD
Zafirlukast—Dizziness—Docetaxel—pancreatic cancer	0.000155	0.00087	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000155	0.000869	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—pancreatic cancer	0.000153	0.000856	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—pancreatic cancer	0.000153	0.000856	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—pancreatic cancer	0.000151	0.000846	CcSEcCtD
Zafirlukast—Vomiting—Docetaxel—pancreatic cancer	0.000149	0.000836	CcSEcCtD
Zafirlukast—Rash—Docetaxel—pancreatic cancer	0.000148	0.00083	CcSEcCtD
Zafirlukast—Dermatitis—Docetaxel—pancreatic cancer	0.000148	0.000829	CcSEcCtD
Zafirlukast—Headache—Docetaxel—pancreatic cancer	0.000147	0.000824	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—pancreatic cancer	0.000146	0.000821	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—pancreatic cancer	0.000145	0.000816	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000144	0.000808	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000143	0.000804	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—pancreatic cancer	0.000143	0.000803	CcSEcCtD
Zafirlukast—Nausea—Docetaxel—pancreatic cancer	0.000139	0.000781	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—pancreatic cancer	0.000139	0.000781	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000137	0.000766	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—pancreatic cancer	0.000136	0.000765	CcSEcCtD
Zafirlukast—Pain—Epirubicin—pancreatic cancer	0.000135	0.000759	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000133	0.000748	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—pancreatic cancer	0.000132	0.000743	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—pancreatic cancer	0.00013	0.000731	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000129	0.000726	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—pancreatic cancer	0.000129	0.000723	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000126	0.000709	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—pancreatic cancer	0.000126	0.000708	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—pancreatic cancer	0.000126	0.000705	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—pancreatic cancer	0.000125	0.000702	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—pancreatic cancer	0.000125	0.000701	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—pancreatic cancer	0.000125	0.000701	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000121	0.000677	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00012	0.000671	CcSEcCtD
Zafirlukast—Hypersensitivity—Epirubicin—pancreatic cancer	0.000117	0.000654	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—pancreatic cancer	0.000116	0.000652	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—pancreatic cancer	0.000116	0.000649	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—pancreatic cancer	0.000116	0.000649	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—pancreatic cancer	0.000114	0.000637	CcSEcCtD
Zafirlukast—Pruritus—Epirubicin—pancreatic cancer	0.000112	0.000628	CcSEcCtD
Zafirlukast—Diarrhoea—Epirubicin—pancreatic cancer	0.000108	0.000607	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000108	0.000605	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—pancreatic cancer	0.000105	0.000589	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—pancreatic cancer	0.000105	0.000587	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—pancreatic cancer	0.000104	0.000581	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—pancreatic cancer	0.000101	0.000564	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—pancreatic cancer	0.0001	0.000562	CcSEcCtD
Zafirlukast—Rash—Epirubicin—pancreatic cancer	9.98e-05	0.00056	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—pancreatic cancer	9.97e-05	0.000559	CcSEcCtD
Zafirlukast—Headache—Epirubicin—pancreatic cancer	9.91e-05	0.000556	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—pancreatic cancer	9.68e-05	0.000543	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—pancreatic cancer	9.4e-05	0.000527	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—pancreatic cancer	9.31e-05	0.000522	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—pancreatic cancer	9.23e-05	0.000518	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—pancreatic cancer	9.22e-05	0.000517	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—pancreatic cancer	9.17e-05	0.000514	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—pancreatic cancer	8.7e-05	0.000488	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—CASP3—pancreatic cancer	3.05e-05	0.000353	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GLP1R—pancreatic cancer	3.05e-05	0.000353	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—DPYD—pancreatic cancer	3e-05	0.000347	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CG—pancreatic cancer	3e-05	0.000347	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3e-05	0.000347	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NRAS—pancreatic cancer	3e-05	0.000347	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCND1—pancreatic cancer	2.97e-05	0.000344	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGF—pancreatic cancer	2.97e-05	0.000343	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CTNNB1—pancreatic cancer	2.94e-05	0.00034	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GLP1R—pancreatic cancer	2.93e-05	0.000339	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—DPYD—pancreatic cancer	2.88e-05	0.000334	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MMP9—pancreatic cancer	2.88e-05	0.000334	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTEN—pancreatic cancer	2.87e-05	0.000332	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC2A2—pancreatic cancer	2.85e-05	0.00033	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AKT1—pancreatic cancer	2.8e-05	0.000324	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.77e-05	0.00032	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC2A2—pancreatic cancer	2.74e-05	0.000317	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EGFR—pancreatic cancer	2.73e-05	0.000317	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TYMP—pancreatic cancer	2.72e-05	0.000315	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.71e-05	0.000314	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ARG2—pancreatic cancer	2.69e-05	0.000311	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SRC—pancreatic cancer	2.66e-05	0.000308	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CD—pancreatic cancer	2.64e-05	0.000305	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.61e-05	0.000303	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.61e-05	0.000303	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VEGFA—pancreatic cancer	2.59e-05	0.0003	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—KRAS—pancreatic cancer	2.58e-05	0.000299	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT3—pancreatic cancer	2.56e-05	0.000297	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NRAS—pancreatic cancer	2.56e-05	0.000296	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.54e-05	0.000295	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.52e-05	0.000292	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.4e-05	0.000278	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—pancreatic cancer	2.38e-05	0.000276	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.38e-05	0.000276	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—pancreatic cancer	2.38e-05	0.000275	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.37e-05	0.000275	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.35e-05	0.000272	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—pancreatic cancer	2.33e-05	0.00027	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CB—pancreatic cancer	2.3e-05	0.000266	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL8—pancreatic cancer	2.21e-05	0.000256	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.21e-05	0.000255	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CD44—pancreatic cancer	2.2e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KRAS—pancreatic cancer	2.2e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRAS—pancreatic cancer	2.19e-05	0.000254	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GLP1R—pancreatic cancer	2.19e-05	0.000254	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ARG2—pancreatic cancer	2.19e-05	0.000253	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PRSS1—pancreatic cancer	2.15e-05	0.00025	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—DPYD—pancreatic cancer	2.15e-05	0.000249	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—pancreatic cancer	2.13e-05	0.000247	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CD44—pancreatic cancer	2.12e-05	0.000245	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CASP3—pancreatic cancer	2.11e-05	0.000245	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GCG—pancreatic cancer	2.11e-05	0.000245	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.1e-05	0.000243	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.07e-05	0.00024	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—pancreatic cancer	2.06e-05	0.000238	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.06e-05	0.000238	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	2.04e-05	0.000237	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CTNNB1—pancreatic cancer	2.04e-05	0.000236	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GCG—pancreatic cancer	2.03e-05	0.000235	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—pancreatic cancer	2.02e-05	0.000234	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—pancreatic cancer	2e-05	0.000231	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—STK11—pancreatic cancer	1.99e-05	0.00023	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—pancreatic cancer	1.99e-05	0.00023	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—pancreatic cancer	1.96e-05	0.000226	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—pancreatic cancer	1.94e-05	0.000224	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.94e-05	0.000224	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.93e-05	0.000223	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.91e-05	0.000221	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—STK11—pancreatic cancer	1.91e-05	0.000221	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.89e-05	0.000219	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—pancreatic cancer	1.87e-05	0.000217	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.87e-05	0.000216	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.86e-05	0.000216	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SRC—pancreatic cancer	1.84e-05	0.000213	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—pancreatic cancer	1.79e-05	0.000208	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.79e-05	0.000208	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—pancreatic cancer	1.78e-05	0.000206	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRAS—pancreatic cancer	1.77e-05	0.000205	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.77e-05	0.000205	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.75e-05	0.000203	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.73e-05	0.0002	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TYMS—pancreatic cancer	1.71e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.69e-05	0.000196	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.69e-05	0.000195	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.66e-05	0.000193	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.66e-05	0.000192	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—pancreatic cancer	1.65e-05	0.000191	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—pancreatic cancer	1.65e-05	0.000191	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—pancreatic cancer	1.65e-05	0.000191	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TYMS—pancreatic cancer	1.64e-05	0.00019	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.63e-05	0.000189	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—pancreatic cancer	1.61e-05	0.000187	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CD44—pancreatic cancer	1.58e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.58e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.58e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.56e-05	0.000181	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.55e-05	0.00018	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.54e-05	0.000178	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.54e-05	0.000178	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.53e-05	0.000177	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KRAS—pancreatic cancer	1.53e-05	0.000177	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GCG—pancreatic cancer	1.52e-05	0.000176	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.52e-05	0.000176	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.51e-05	0.000174	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.45e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.44e-05	0.000167	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.44e-05	0.000167	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—STK11—pancreatic cancer	1.43e-05	0.000165	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.42e-05	0.000165	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.4e-05	0.000162	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—APOE—pancreatic cancer	1.39e-05	0.000161	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.37e-05	0.000159	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.37e-05	0.000159	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CD44—pancreatic cancer	1.37e-05	0.000158	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—pancreatic cancer	1.36e-05	0.000157	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.35e-05	0.000156	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.34e-05	0.000155	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—APOE—pancreatic cancer	1.34e-05	0.000155	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.33e-05	0.000154	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.32e-05	0.000152	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GCG—pancreatic cancer	1.31e-05	0.000152	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—pancreatic cancer	1.3e-05	0.00015	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.29e-05	0.00015	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.26e-05	0.000146	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.26e-05	0.000146	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.25e-05	0.000145	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.25e-05	0.000145	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—STK11—pancreatic cancer	1.23e-05	0.000143	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.23e-05	0.000142	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TYMS—pancreatic cancer	1.23e-05	0.000142	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CD44—pancreatic cancer	1.22e-05	0.000141	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.22e-05	0.000141	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARG—pancreatic cancer	1.21e-05	0.00014	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CG—pancreatic cancer	1.21e-05	0.00014	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.2e-05	0.000139	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.18e-05	0.000137	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.17e-05	0.000136	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GCG—pancreatic cancer	1.17e-05	0.000136	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—pancreatic cancer	1.16e-05	0.000135	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.16e-05	0.000134	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—pancreatic cancer	1.14e-05	0.000133	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CD44—pancreatic cancer	1.12e-05	0.00013	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CD44—pancreatic cancer	1.11e-05	0.000129	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.1e-05	0.000128	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—STK11—pancreatic cancer	1.1e-05	0.000128	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.09e-05	0.000126	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.08e-05	0.000125	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GCG—pancreatic cancer	1.08e-05	0.000125	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.07e-05	0.000124	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GCG—pancreatic cancer	1.07e-05	0.000124	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.06e-05	0.000123	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.06e-05	0.000123	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.03e-05	0.00012	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.02e-05	0.000118	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—STK11—pancreatic cancer	1.01e-05	0.000117	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—STK11—pancreatic cancer	1e-05	0.000116	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.99e-06	0.000116	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOE—pancreatic cancer	9.98e-06	0.000116	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CB—pancreatic cancer	9.62e-06	0.000111	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—pancreatic cancer	9.53e-06	0.00011	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CD44—pancreatic cancer	9.52e-06	0.00011	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.48e-06	0.00011	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMS—pancreatic cancer	9.47e-06	0.00011	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.42e-06	0.000109	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.32e-06	0.000108	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CB—pancreatic cancer	9.24e-06	0.000107	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.23e-06	0.000107	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—pancreatic cancer	9.15e-06	0.000106	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GCG—pancreatic cancer	9.12e-06	0.000106	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	9.01e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMS—pancreatic cancer	8.71e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—pancreatic cancer	8.7e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMS—pancreatic cancer	8.63e-06	0.0001	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOE—pancreatic cancer	8.63e-06	9.99e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—STK11—pancreatic cancer	8.58e-06	9.94e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—pancreatic cancer	8.31e-06	9.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.17e-06	9.46e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.05e-06	9.33e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—pancreatic cancer	7.98e-06	9.25e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	7.92e-06	9.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	7.79e-06	9.02e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOE—pancreatic cancer	7.7e-06	8.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—pancreatic cancer	7.52e-06	8.7e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMS—pancreatic cancer	7.38e-06	8.55e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CD44—pancreatic cancer	7.34e-06	8.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.29e-06	8.44e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOE—pancreatic cancer	7.08e-06	8.2e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GCG—pancreatic cancer	7.04e-06	8.16e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOE—pancreatic cancer	7.02e-06	8.13e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	6.95e-06	8.05e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	6.9e-06	8e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	6.85e-06	7.93e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—pancreatic cancer	6.84e-06	7.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.71e-06	7.77e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.65e-06	7.7e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—STK11—pancreatic cancer	6.62e-06	7.67e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	6.39e-06	7.4e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	6.34e-06	7.34e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—pancreatic cancer	6.17e-06	7.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—pancreatic cancer	6.12e-06	7.08e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	6.11e-06	7.08e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOE—pancreatic cancer	6e-06	6.95e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	5.97e-06	6.91e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—pancreatic cancer	5.97e-06	6.91e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—pancreatic cancer	5.91e-06	6.85e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—pancreatic cancer	5.86e-06	6.79e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.69e-06	6.6e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.68e-06	6.58e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—pancreatic cancer	5.63e-06	6.52e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.62e-06	6.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.57e-06	6.45e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	5.42e-06	6.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	5.33e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—pancreatic cancer	5.28e-06	6.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—pancreatic cancer	5.23e-06	6.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—pancreatic cancer	5.16e-06	5.97e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.9e-06	5.67e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.86e-06	5.62e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.85e-06	5.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.81e-06	5.57e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—pancreatic cancer	4.79e-06	5.55e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.76e-06	5.51e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOE—pancreatic cancer	4.63e-06	5.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.6e-06	5.33e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—pancreatic cancer	4.6e-06	5.33e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.23e-06	4.9e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	4.21e-06	4.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—pancreatic cancer	4.2e-06	4.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.18e-06	4.84e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	4.15e-06	4.81e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—pancreatic cancer	4.11e-06	4.76e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.03e-06	4.67e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.67e-06	4.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.64e-06	4.21e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.59e-06	4.15e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—pancreatic cancer	3.44e-06	3.98e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.25e-06	3.76e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.2e-06	3.71e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.17e-06	3.68e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.99e-06	3.46e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.97e-06	3.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.96e-06	3.43e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.77e-06	3.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.65e-06	3.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.53e-06	2.93e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.44e-06	2.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.07e-06	2.39e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.95e-06	2.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.59e-06	1.85e-05	CbGpPWpGaD
